retatrutide phase 2 trial new england journal of medicine approval: FDA status, clinical results, and when it could be available Retatrutide Helped Adults With Obesity

For those looking to achieve and maintain weight loss, GLP-1 medications offer a promising option to support long-term success

These calculations are based on a 100-unit insulin syringe where 1 mL equals 100 units

New England Journal of Medicine, 384(11), 989-1002

Simultaneous GLP-1 and insulin administration acutely enhances their vasodilatory, antiinflammatory and antioxidant action in type 2 diabetes

Compounded GLP-1 medications require proper cold-chain handling during shipping and storage

For once-weekly injections, administer the missed dose as soon as possible if within the specified timeframe (e.g., within 5 days for semaglutide, at least 3 days before the next dose for dulaglutide)